Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2007
Disseminated iodine-avid lung metastases in differentiated thyroid cancer: a challenge to 124I PETLutz S Freudenberg, Walter Jentzen, Stefan P Müller, et al.
Deutsches Arzteblatt International|July 25, 2015
The Treatment of Well-Differentiated Thyroid CarcinomaRalf Paschke, Thomas Lincke, Stefan P Müller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 9, 2016
Lymphocyte function following radium-223 therapy in patients with metastasized, castration-resistant prostate cancerVahé Barsegian, Stefan P Müller, Daniel Möckel, et al.
Nuclear Medicine Communications|March 5, 2008
Influence of various geometric factors on the iodine-131 uptake measurement for solitary thyroid nodulesWalter Jentzen, Rainer Görges, Lutz Freudenberg, et al.
Leukemia & Lymphoma|February 6, 2020
Metabolic tumor volume, cancer cell fraction, and prognosis - the case of T-cell/histiocyte-rich large B-cell lymphomaChristine Schmitz, Jan Rekowski, Sarah Reinke, et al.
Physics in Medicine and Biology|August 4, 2005
Measures of performance in nonlinear estimation tasks: prediction of estimation performance at low signal-to-noise ratioStefan P Müller, Craig K Abbey, Frank J Rybicki, et al.
Medical Physics|April 6, 2013
Performance of a high-sensitivity dedicated cardiac SPECT scanner for striatal uptake quantification in the brain based on analysis of projection dataMi-Ae Park, Stephen C Moore, Stefan P Müller, et al.
Nuklearmedizin. Nuclear Medicine|March 14, 2018
[Selective intraarterial radiotherapy (SIRT) of malignant liver tumors]Stefan P Müller, Samer Ezziddin, Gerald Antoch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2005
Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinationsGunnar Brix, Ursula Lechel, Gerhard Glatting, et al.
European Radiology|November 16, 2007
Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancerLutz S Freudenberg, Andrea Frilling, Hilmar Kühl, et al.
Pageof 3